INTRODUCTION
Antigenic differences between rubella wild-type and vaccine RA27/3 strains are slight and have been demonstrated only by neutralisation (Fogel and Plotkin, 1969; Oxford, 1969) and by neutralisation kinetics (Gould and Butler, 1980) . In this report, we have compared wild-type and RA27/3 strains by the more sensitive techniques of polyacrylamide-gel electrophoresis and competitive radioimmune precipitation.
MATERIALS AND METHODS
Cells, virus, culture media and bufers were as described by Ho-Terry and Cohen (1979) . Vaccine virus strain RA27/3 was kindly supplied by Dr A. J. Beale, The Wellcome Research Laboratories, Beckenham, Kent. The virus was used as supplied without any more passages in tissue-culture cells. Wild-type rubella virus strain 'Judith' was supplied by Professor J. A. Dudgeon.
Unlabelled and in-vivo labelled virus was prepared as described by Ho-Terry and Cohen (1979) and externally labelled virus as described by Bolton and Hunter (1973) . Concentration and purification of virus was as described by Ho-Terry and Cohen (1979) .
Radioactive isotopes. L-(S3H) arginine monohydrochloride (8.8 Ci/mmol) and N-succinimidyl (2,3-3H) propionate (3&60 Ci/mmol) were obtained from the Radiochemical Centre, Amersham, Bucks HP7 9LL.
Sera. Post-infection sera were obtained from Dr T. H. Flewett, Regional Virus Laboratory, East Birmingham Hospital, Birmingham B9 5HT, and the post-vaccination sera from Dr A. J. Beale. Goat anti-human IgG serum was from Miles Laboratories Ltd., Slough, Berks.
Polyacrylamide gel-electrophoresis was as described by Laemmli ( 1970) . Competitive radioimmune precipitation. 3H-arginine-labelled wild-type rubella virus, diluted to a haemagglutination titre of 128, was mixed with either unlabelled RA27/3 virus with the same haemagglutination titre or phosphate-buffered saline in equal volumes. Either antigenic mixture (0.2 ml) was reacted with a post-infection or post-vaccination serum (0.1 ml) diluted to a haemagglutination inhibition titre not greater than 32 and held at room temperature for 2 h. Any virus-antibody complexes formed were then precipitated by an appropriate dilution of a goat anti-human IgG serum. The radioactivity associated with the immune complexes was measured as previously described (Ho-Terry and Cohen, 1979) .
Haemagglutination and haemagglutination inhibition were assayed as described by Liebhaber (1970a and 6) .
RESULTS

Sedimentation characteristics
Purified intact wild-type rubella virus and RA27/3 vaccine virus concentrate were centrifuged at 200000 g in discontinuous 5-45% (w/v) sucrose gradients for 2 h at 4°C. Fractions (6 drops) were collected and dialysed against phosphate-buffered saline and titrated for haemagglutinating activity. The results, summarised in fig. 1 , show that the sedimentation characteristics of wild-type and RA27/3 vaccine virus strains are identical.
Polyacrylamide-gel electrophoresis
Wild-type and RA27/3 strains, concentrated and purified as described, were externally labelled with 3H-succinimidyl propionate. To remove any contamination with host protein constituents the externally labelled wild type and RA27/3 strains were immunoprecipitated with a human post-infection serum or a human post-RA27/3 vaccination serum respectively before electrophoresis in polyacrylamide gels. Analysis of the polypeptide patterns ( fig. 2 ) revealed that the pattern of the wild-type virus conformed to that previously reported for in-vivo labelled rubella virus, (Ho-Terry and Cohen, 1980) and consists of three virion polypeptides with molecular weights of 55 K, 45 K and 33 K, respectively. The pattern obtained with RA27/3 was very similar and there were no significant differences. The labelling of the internal nucleocapsid polypeptide 33 K (Ho-Terry and Cohen, 1979) in both viruses suggests some fragmentation of the viral envelope during external labelling.
Immunological r ela t ions h ip
To characterise wild-type and RA27/3 strains immunologically they were analysed by competitive radioimmune precipitation in which wild-type virus, in-vivo labelled with 3H-arginine, was reacted, in the presence or absence of strain RA27/3, with human antibodies elicited by natural infection or vaccination with strain RA27/3. Any virus-antibody complexes formed were then precipitated by antibodies to human IgG (goat anti-human IgG antibodies) so that the total radio-activity precipitated was the total antibody activity directed against wild-type virus. The ratio of radioactivity precipitated in the presence or absence of strain RA27/3 was thus the proportion of antibody in each serum that exhibited greater affinity for wild type compared with RA27/3. The results, summarised in the table and illustrated in fig. 3 , show that wild-type rubella virus has a greater affinity for the antibodies in post-infection sera and virus strain RA73/3 has a greater affinity for the antibodies in post-vaccination sera.
DISCUSSION
The virion polypeptide pattern of rubella virus has been reported previously (Liebhaber and Gross, 1972; Vaheri and Hovi, 1972; Bardeletti, Kessler and Aymard-Henry, 1975; Payment, Adjukovic and Pavilanis, 1975; Ho-Terry and Cohen, 1980; van Alstyne et al., 198 l) , but so far a comparison between wild-type and vaccine strains has not been made. Our results show that the electrophoretic pattern and the molecular weights of the RA27/3 virion polypeptides are identical to those of the wild type ( fig. 2 ). Although identical in this respect, the two viruses are distinguishable in competitive radioimmune precipitation assays. Post-infection and post-vaccination sera reacted well with radioactively labelled wild-type virus, but a difference in specificity was revealed when the reaction was challenged with strain RA27/3 (table I and fig. 3 ), suggesting the existence of strain-specific antigens and that these strains although closely related are not identical.
The antigenic difference demonstrated by competitive radioimmune precipitation assay may have practical as well as theoretical importance. In persons naturally infected with rubella, the antibody response after reinfection is characteristically IgG without IgM, whereas reinfection after vaccination may ind6ce an IgM response (Harcourt, Best and Banatvala, 1980; Cradock-Watson et al., 1981) . This suggests contact after reinfection with an antigen not previously experienced by vaccinated individuals. This might explain the greater susceptibility of vaccinated individuals to reinfection and the possible greater risk to the fetus if this occurs during pregnancy (Plotkin, Farquar and Ogra, 1973) . Significantly, IgM antibodies to other viruses of the family Togaviridae have been shown to be more specific than antibodies of the IgG class (Westaway, Della-Porta and Reedman, 1974) .
The radioimmune precipitation technique measures antibodies directed against surface antigens (Ho-Terry and Cohen, 1980) . Any strain-specific antigenic determinant therefore probably resides in the virion glycoproteins. Recently, we suggested that 55 K and 45 K glycoproteins of rubella virus may carry the antigenic components for haemagglutination-inhibition and neutralising antibodies respectively (Ho-Terry and Cohen, 1980) . Because strain specificity of rubella virus has previously been demonstrated only by neutralisation techniques and not by haemagglutination inhibition (Fogel and Plotkin, 1969; Oxford, 1969; Best and Banatvala 1970; Gould and Butler 1980) , the antigenic specificity demonstrable by competitive radioimmune precipitation may reside in the 45-K rather than the 55-K component, thus accounting for the broad cross reactivity of haemagglutination-inhibition antibody and the greater specificity of neutralising antibody. We thank Dr T.H. Flewett and Dr A. J. Beale for the rubella antisera and the RA27/3 rubella vaccine.
